Document Detail


Chronic angina: definition, prevalence, and implications for quality of life.
MedLine Citation:
PMID:  19898285     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Chronic angina is a prevalent manifestation of cardiovascular disease and is most commonly due to insufficient oxygen supply from fixed epicardial lesions in the coronary arteries. In addition to increasing the risk of cardiovascular death and recurrent myocardial infarction, chronic angina has a significant impact on functional capacity and quality of life. All patients with cardiovascular disease should be closely questioned to determine the functional and symptomatic limitations attributable to ischemic symptoms. The Canadian Cardiovascular Society Classification of Angina is the easiest metric to use; however, more sensitive measures such as the Seattle Angina Questionnaire offer a better overall assessment of angina symptoms and quality of life and can be used to compare the efficacy of different treatments. Treatment strategies that begin with either immediate revascularization or optimal medical therapy with antianginal agents significantly improve angina frequency and quality of life. Initial revascularization, especially with coronary artery bypass grafting, appears to offer more rapid relief of angina compared with percutaneous coronary intervention or medical therapy in the first months after initial revascularization. After a year of follow-up, though, much of the treatment differences are lost and all strategies (surgical/percutaneous revascularization or medical therapy) result in a significant improvement of angina symptoms.
Authors:
Benjamin M Scirica
Related Documents :
1951105 - The role of coronary angioplasty in the management of unstable angina pectoris.
8260275 - Myocardial ischaemia and angina in the early post-infarction period: a comparison with ...
21338715 - Coronary artery disease affecting the atrial branches is an independent determinant of ...
8829955 - Remodelling of the coronary arteries after thrombolysis.
17049635 - Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging.
21997165 - Clinical and electrocardiography changes in patients treated with capecitabine.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Reviews in cardiovascular medicine     Volume:  10 Suppl 1     ISSN:  1530-6550     ISO Abbreviation:  Rev Cardiovasc Med     Publication Date:  2009  
Date Detail:
Created Date:  2009-11-09     Completed Date:  2010-11-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100960007     Medline TA:  Rev Cardiovasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S3-10     Citation Subset:  IM    
Affiliation:
TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angina Pectoris / diagnosis,  epidemiology,  etiology,  physiopathology,  therapy*
Cardiovascular Agents / therapeutic use*
Chronic Disease
Coronary Artery Disease / complications,  diagnosis,  epidemiology,  physiopathology,  therapy*
Coronary Circulation
Humans
Myocardial Revascularization*
Prevalence
Quality of Life*
Questionnaires
Recovery of Function
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Cardiovascular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluating medical, percutaneous coronary intervention, and coronary artery bypass surgery options f...
Next Document:  Cardiovascular imaging to risk-stratify in chronic angina.